Stocktoria
BiomX Inc. PHGE
NYSE American · XASE · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-12-18
BiomX Inc. financials (annual, from 10-K)
Bars are annual figures from 2018 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| R&D expense | $21.3M | $24.7M | $16.7M | $16.2M | $22.7M | $19.4M | $13.5M | — | $9.1M |
| Operating income | -$41.5M | -$44.5M | -$25.3M | -$27.2M | -$35.5M | -$30.3M | -$22.2M | -$404,521 | -$12.5M |
| Interest expense | — | — | $2.4M | $2.1M | $699,000 | — | — | — | — |
| Income tax | $7,000 | $13,000 | $23,000 | $65,000 | $67,000 | — | — | $135,197 | — |
| Net income | -$36.2M | -$17.7M | -$26.2M | -$28.3M | -$36.2M | -$30.1M | -$20.6M | $347,407 | -$12.7M |
| EPS (diluted) | $22.19 | $58.31 | $5.10 | $0.95 | $1.39 | — | — | — | — |
| Operating cash flow | -$26.4M | -$37.0M | -$21.3M | -$29.1M | -$27.6M | -$24.4M | -$17.6M | -$204,579 | -$11.3M |
| Free cash flow | -$26.4M | -$37.0M | -$21.3M | -$29.2M | -$31.3M | -$25.5M | -$18.9M | — | -$11.4M |
| Cash & equivalents | $4.4M | $16.9M | $14.9M | $31.3M | $62.1M | $36.5M | $72.3M | $696,830 | $8.6M |
| Total assets | $5.8M | $43.2M | $25.0M | $45.5M | $78.0M | $70.4M | $92.1M | $71.6M | $45.3M |
| Total liabilities | $7.1M | — | — | — | — | — | — | $871,011 | $541,382 |
| Shareholders' equity | -$1.3M | $24.1M | $3.1M | $21.0M | $47.5M | $57.5M | $84.5M | $38.2M | $42.8M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net income growth | — | — | — | — | — | — | -6019.0% | — | — |
| EPS growth | -61.9% | +1043.3% | +436.8% | -31.7% | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0001739174 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.